Intended for licensed healthcare professionals located in the United Kingdom only.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions
This medicinal product has been authorised under a 'conditional approval' scheme
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via their national reporting system.
Adverse reactions should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk.
Adverse events should also be reported to Incyte immediately by phoning 0330‑100‑3677 (Great Britain) or 00‑800‑0002‑7423 (United Kingdom [Northern Ireland]).